Failed Long Covid Drug Trial Offers Study Design Insights
A Phase 2 clinical trial of the drug BC 007 for long Covid failed due to poor study design, including unreliable participant selection and outcome measures, highlighting the complexities of researching this diverse condition. Despite the setback, future research is planned with improved methods, and other studies have shown more promising results in specific subgroups, emphasizing the need for precise patient stratification and collaboration with patients in trial design.